Impactive Capital discloses 3.5% Clarivate (CLVT) stake in Schedule 13D/A

Rhea-AI Filing Summary

Clarivate plc received an amended ownership report from Impactive Capital and related reporting persons. They report beneficial ownership of 23,021,664 Clarivate ordinary shares, representing 3.5% of the class based on 661,435,069 shares outstanding as of September 30, 2025, as disclosed in Clarivate’s Form 10-Q.

The filing states that the shares were purchased for the Impactive funds using working capital, which may include margin loans, in open‑market transactions. An aggregate of approximately $146,406,907, including brokerage commissions, was used to acquire these shares. This Amendment No. 1 updates prior Schedule 13D disclosures, including source of funds and current ownership details, and references recent trading activity listed in an attached schedule.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 1)

CLARIVATE PLC

(Name of Issuer)

Ordinary Shares, no par value per share

(Title of Class of Securities)

G21810109

(CUSIP Number)

Lauren Taylor Wolfe
Impactive Capital LP, 450 West 14th Street, 12th Floor
New York, NY, 10014
212-218-8810

Christain Asmar
Impactive Capital LP, 450 West 14th Street, 12th Floor
New York, NY, 10014
212-218-8810

Ele Klein & Adriana Schwartz
McDermott Will & Schulte LLP, 919 Third Avenue
New York, NY, 10022
(212) 756-2000

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

02/04/2026

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13D

CUSIP No. G21810109

1

Name of reporting person

Impactive Capital LP

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 23,021,664.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 23,021,664.00

11

Aggregate amount beneficially owned by each reporting person

23,021,664.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

3.5 %

14

Type of Reporting Person (See Instructions)

IA, PN

SCHEDULE 13D

CUSIP No. G21810109

1

Name of reporting person

Impactive Capital LLC

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 23,021,664.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 23,021,664.00

11

Aggregate amount beneficially owned by each reporting person

23,021,664.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

3.5 %

14

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13D

CUSIP No. G21810109

1

Name of reporting person

Lauren Taylor Wolfe

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 23,021,664.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 23,021,664.00

11

Aggregate amount beneficially owned by each reporting person

23,021,664.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

3.5 %

14

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13D

CUSIP No. G21810109

1

Name of reporting person

Christian Asmar

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 23,021,664.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 23,021,664.00

11

Aggregate amount beneficially owned by each reporting person

23,021,664.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

3.5 %

14

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Ordinary Shares, no par value per share
(b)	Name of Issuer: CLARIVATE PLC
(c)	Address of Issuer's Principal Executive Offices: 4TH FLOOR, ST. PAUL'S GATE, 22-24 NEW STREET, ST. HELIER, JERSEY , JE14TR.
Item 1 Comment: The following constitutes Amendment No. 1 ("Amendment No. 1") to the Schedule 13D filed with the Securities and Exchange Commission (the "SEC") on October 16, 2023 (as amended, the "Schedule 13D"). This Amendment No. 1 amends and restates Items 3 and 5(a)-(c) and (e) as set forth below. Capitalized terms used herein and not otherwise defined in this Amendment No. 1 have the meanings set forth in the Schedule 13D.
Item 3.	Source and Amount of Funds or Other Consideration
	The Shares reported herein were purchased with working capital of the Impactive Funds (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market purchases. An aggregate of approximately $146,406,907, including brokerage commissions, was used to acquire the Shares reported herein.
Item 5.	Interest in Securities of the Issuer
(a)	See rows (11) and (13) of the cover pages to this Schedule 13D for the aggregate number of Shares and percentage of Shares beneficially owned by each Reporting Person. The aggregate percentage of Shares reported to be beneficially owned by each Reporting Person is based upon 661,435,069 Shares outstanding as of September 30, 2025, as disclosed in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025, filed with the SEC on October 29, 2025.
(b)	See rows (7) through (10) of the cover pages to this Schedule 13D for the number of Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition.
(c)	The transactions in the Shares effected by the Reporting Persons during the past sixty (60) days are set forth on Schedule A attached hereto and incorporated by reference herein.
(e)	February 4, 2026.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Impactive Capital LP

Signature:	/s/ Lauren Taylor Wolfe
Name/Title:	By: Impactive Capital LLC, General Partner, By: Lauren Taylor Wolfe, Managing Member
Date:	02/06/2026

Impactive Capital LLC

Signature:	/s/ Lauren Taylor Wolfe
Name/Title:	Lauren Taylor Wolfe, Managing Member
Date:	02/06/2026

Lauren Taylor Wolfe

Signature:	/s/ Lauren Taylor Wolfe
Name/Title:	Lauren Taylor Wolfe, Individually
Date:	02/06/2026

Christian Asmar

Signature:	/s/ Christian Asmar
Name/Title:	Christian Asmar, Individually
Date:	02/06/2026

FAQ

What percentage of Clarivate (CLVT) does Impactive Capital report owning?

Impactive Capital and related reporting persons report beneficial ownership of 3.5% of Clarivate’s ordinary shares. This percentage is based on 661,435,069 shares outstanding as of September 30, 2025, as disclosed in Clarivate’s Form 10-Q for that quarterly period.

How many Clarivate (CLVT) shares are beneficially owned by Impactive Capital?

The reporting persons disclose beneficial ownership of 23,021,664 Clarivate ordinary shares. This aggregate amount appears consistently on each cover page for Impactive Capital, Impactive Capital LLC, Lauren Taylor Wolfe, and Christian Asmar, reflecting their shared voting and dispositive power over the same block of shares.

How much has Impactive Capital spent acquiring its Clarivate (CLVT) position?

The filing states that approximately $146,406,907, including brokerage commissions, was used to acquire the reported Clarivate shares. These purchases were funded with the working capital of the Impactive funds, which may include margin loans made by brokerage firms in the ordinary course of business.

What is the share count used to calculate Impactive Capital’s 3.5% Clarivate stake?

The 3.5% ownership figure is calculated using 661,435,069 Clarivate ordinary shares outstanding as of September 30, 2025. This outstanding share count is taken from Clarivate’s Form 10-Q for the quarter ended September 30, 2025, filed on October 29, 2025.

Who are the reporting persons in the Clarivate (CLVT) Schedule 13D/A Amendment No. 1?

The reporting persons are Impactive Capital, Impactive Capital LLC, Lauren Taylor Wolfe, and Christian Asmar. Each reports shared voting and dispositive power over 23,021,664 Clarivate ordinary shares, with citizenship or organization disclosed as Delaware entities or United States individuals.

How were Impactive Capital’s Clarivate (CLVT) shares acquired according to the filing?

The filing explains that the Clarivate shares were acquired in open market purchases for the Impactive funds. They were bought using the funds’ working capital, which can include margin loans from brokerage firms obtained in the ordinary course of business, and the total acquisition cost was about $146,406,907.